ArticleRheumatology and therapy2020

A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis.

Hisashi Yamanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.